Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-08 Sale | 2024-01-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 590 | $29.96 | $17,676 | 46,901 (Direct) | View |
| 2023-10-06 Sale | 2023-10-06 10:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 16,369 | $21.96 | $359,463 | 106,146 (Direct) | View |
| 2023-05-01 Sale | 2023-05-02 7:06 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 917 | $21.18 | $19,422 | 25,513 (Direct) | View |
| 2023-04-06 Sale | 2023-04-07 8:32 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 1,456 | $18.16 | $26,441 | 37,744 (Direct) | View |
| 2023-02-24 Sale | 2023-02-27 9:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 803 | $18.78 | $15,080 | 24,536 (Direct) | View |
| 2023-01-09 Sale | 2023-01-10 8:20 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 589 | $17.13 | $10,090 | 20,331 (Direct) | View |
| 2022-05-02 Sale | 2022-05-03 8:51 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 894 | $18.18 | $16,255 | 19,747 (Direct) | View |
| 2022-02-23 Sale | 2022-02-25 5:42 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 782 | $23.8 | $18,612 | 21,273 (Direct) | View |
| 2022-01-06 Sale | 2022-01-10 6:24 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 574 | $23.05 | $13,231 | 16,467 (Direct) | View |
| 2021-04-30 Sale | 2021-04-30 6:54 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 1,054 | $20.33 | $21,428 | 17,381 (Direct) | View |
| 2021-02-04 Sale | 2021-02-08 9:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 2,107 | $50.61 | $106,635 | 9,911 (Direct) | View |
| 2021-01-06 Sale | 2021-01-08 7:30 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 678 | $53.34 | $36,165 | 10,418 (Direct) | View |
| 2020-10-27 Sale | 2020-10-29 4:12 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 8,750 | $45.1 | $394,636 | 117,601 (Direct) | View |
| 2020-04-30 Sale | 2020-05-01 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 1,072 | $49.22 | $52,764 | 11,456 (Direct) | View |
| 2019-12-11 Sale | 2019-12-13 5:34 pm | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 17,500 | $45.06 | $788,576 | 123,009 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-06 Exercise | 2024-01-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 1,634 | $0 | 46,901 (Direct) | View |
| 2023-10-05 Exercise | 2023-10-06 10:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 36,174 | $0 | 106,146 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-03 9:14 pm | N/A 2033-05-01 | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 78,129 | $0 | 78,129 (Direct) | View |
| 2023-04-29 Exercise | 2023-05-02 7:06 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 3,005 | $0 | 25,513 (Direct) | View |
| 2023-04-05 Exercise | 2023-04-07 8:32 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 4,773 | $0 | 37,744 (Direct) | View |
| 2023-02-23 Exercise | 2023-02-27 9:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 2,214 | $0 | 24,536 (Direct) | View |
| 2023-01-06 Exercise | 2023-01-10 8:20 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 1,633 | $0 | 20,331 (Direct) | View |
| 2022-04-29 Exercise | 2022-05-03 8:51 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 3,005 | $0 | 19,747 (Direct) | View |
| 2022-04-05 Option Award | 2022-04-07 6:47 pm | N/A 2032-04-05 | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP,General Counsel, Secretary | 181,072 | $0 | 181,072 (Direct) | View |
| 2022-02-23 Exercise | 2022-02-25 5:42 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 2,213 | $0 | 21,273 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-10 6:24 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 1,633 | $0 | 16,467 (Direct) | View |
| 2021-04-29 Exercise | 2021-04-30 6:54 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 3,005 | $0 | 17,381 (Direct) | View |
| 2021-02-23 Option Award | 2021-02-25 9:46 pm | N/A 2031-02-23 | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 41,463 | $0 | 41,463 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 9:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 6,009 | $0 | 9,911 (Direct) | View |
| 2021-01-06 Exercise | 2021-01-08 7:30 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 1,633 | $0 | 10,418 (Direct) | View |
| 2020-10-27 Exercise | 2020-10-29 4:12 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 8,750 | $17.58 | 117,601 (Direct) | View |
| 2020-10-27 Exercise | 2020-10-29 4:12 pm | N/A 2028-07-17 | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 8,750 | $0 | 117,601 (Direct) | View |
| 2020-04-29 Exercise | 2020-05-01 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 3,004 | $0 | 11,456 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-08 6:06 pm | N/A 2030-01-06 | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 30,242 | $0 | 30,242 (Direct) | View |
| 2019-12-11 Exercise | 2019-12-13 5:34 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 17,500 | $17.58 | 123,009 (Direct) | View |
| 2019-12-11 Exercise | 2019-12-13 5:34 pm | N/A 2028-07-17 | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 17,500 | $0 | 123,009 (Direct) | View |
| 2019-04-29 Option Award | 2019-05-01 5:58 pm | N/A 2029-04-29 | ACADIA PHARMACEUTICALS INC | ACAD | KIM AUSTIN D. EVP & General Counsel | 54,192 | $0 | 54,192 (Direct) | View |